• Title/Summary/Keyword: 자궁경부암 검사

Search Result 71, Processing Time 0.013 seconds

The thresholding method for cervical cell image segmentation (자궁경부암 세포 영상 분할을 위한 Thresholding 기법)

  • 김재륜;하진영;김백섭;김호성
    • Proceedings of the Korean Information Science Society Conference
    • /
    • 1999.10b
    • /
    • pp.419-421
    • /
    • 1999
  • 본 논문은 자궁경부암 검사를 위한 전처리 과정인 자궁경부암 세포 영상분할 문제 연구의 결과이다. 자궁경부암 세포 영상은 배경과 세포질 및 세포핵의 구별이 어렵다. 게다가 자궁경부암 검사 시스템은 짧은 시간동안 많은 영상을 처리해야 하기 때문에, 영상의 분석 속도가 빠르고 강력한 영상 분할 기법이 필요하다. 이를 위하여 우리는 thresholding 기법을 연구하였다. 먼저 세포 영상의 각 화소의 명암의 분포를 조사하여 히스토그램을 구하였다. 히스토그램은 0~255 사이에 존재하게 되는데, 0~255의 전 영역에 존재하기 보다는 그 중 일부분에만 존재한다. 우리는 히스토그램이 존재하는 영역을 백분율로 나누고 세포핵 및 세포질이 존재하는 영역의 분포를 구하여 global threshold를 찾았고, 이를 기준으로 각 점을 thresholding 할 때에 주위의 평균값을 보정값으로 두어 local thresholding을 수행하였다. 결과 영상은 핵의 영역을 탐색하기 위한 seed로 사용하기에 적합하다.

  • PDF

Spatholobi Caulis Herbal-acupuncture Solution Induced Apoptosis in Human Cervical Cancer Cells, SNU-17 (계형등 약침액이 자궁경부암 세포주 SUN-17의 세포 사멸에 미치는 효과)

  • Seo, Bo-Myung;Lee, Yoon-Kyung;Lee, Bong-Hyo;Lee, Kyung-Min;Lim, Seong-Chul;Jung, Tae-Young;Seo, Jung-Chul
    • Journal of Acupuncture Research
    • /
    • v.24 no.4
    • /
    • pp.107-113
    • /
    • 2007
  • 목적 : 본 연구는 계혈등 약침액이 자궁경부암 세포주 SNU-17에서 세포 사멸 효과가 있는지 알아보고자 하였다. 방법 : 자궁경부암 세포주 SNU-17에서 세포 사멸의 변화를 관찰하기 위해서 MTT cytotoxicity assay, DAPI staining, TUNEL assay, RT-PCR analysis 방법을 이용하였다. 결과 : 세포독성 검사에서 계혈등 약침액은 자궁경부암 세포주 SNU-17에 농도 의존적으로 세포독성을 나타내었다. 이러한 계혈등 약침액의 세포독성이 세포사별로 인한 것인지 다른 기전에 의한 것인지 알아본 결과 계혈등 약침액에 의한 세포독성은 DAPI staining 과 TUNEL assay에서 세포사멸의 특정적인 소견들을 나타내었다. 계혈등 약침액이 Bax, Caspase-3의 발현에 미치는 영향을 RT-PCR로 관찰한 결과 계혈등 약침액은 Bax, Caspase-3의 발현을 증가시켰다. 결론 : 이상의 결과 계혈등 약침액이 자궁경부암 세포주 SNU-17에서 세포 사멸을 야기하여 자궁경부암의 치료에 유용할 것으로 사료된다.

  • PDF

Diagnostic Availability of Estrogen Receptor Alpha mRNA on Cervical Cancer Tissue (자궁경부암 조직에서 에스트로겐 수용체 알파 mRNA의 진단적 유용성)

  • Kim, Geehyuk;Yu, Kwangmin;Kim, Jungho;Kim, Seoyong;Park, Sunyoung;Ahn, Sungwoo;Lee, Ji-Young;Kim, Sunghyun;Park, Ho-Hyun;Lee, Dongsup
    • Korean Journal of Clinical Laboratory Science
    • /
    • v.50 no.4
    • /
    • pp.449-456
    • /
    • 2018
  • Cervical cancer is the fourth most frequently diagnosed cancer in women worldwide. In lower Human Development Index countries, it has the second highest incidence and mortality among cancer in women. Therefore, better diagnosis and treatment systems are needed. Among them, estrogen receptor alpha ($ER-{\alpha}$) mRNA expression has been analyzed with RT-qPCR since several studies reported that $ER-{\alpha}$ is necessary in the maturation of the uterus and is related to cervical cancer. In this study, $ER-{\alpha}$ quantitative analysis was performed on various lesions and normal tissue samples. Based on the receiver operating characteristic (ROC) curve, its sensitivity and specificity were 85% and 75%, respectively, showing higher or similar results to those of conventional HPV tests. In addition, its expression level was analyzed with clinical information. With regression analysis, the R square value between the $ER-{\alpha}$ mRNA expression level and menopause status was 0.5041, indicating a strong correlation. This study was performed as part of a pilot study and suggests that $ER-{\alpha}$ is related to carcinogenesis. Future studies will examine other hormones and menopausal factors with a larger sample size.

Evaluation of Human Papillomavirus Genotyping from Formalin-fixed Paraffin-embedded Specimens in Cervical Cancers (자궁경부암 파라핀 조직에서 인유두종바이러스 유전형 검사의 유용성 평가)

  • Jin, Hyunwoo
    • Journal of Life Science
    • /
    • v.24 no.9
    • /
    • pp.1025-1029
    • /
    • 2014
  • Cervical carcinoma is the second leading cause of cancer-related deaths in women around the world, and it is associated with the Human Papillomavirus (HPV) infection. HPV genotyping is important for vaccine policy, etiology, natural history, and epidemiology studies. The use of formalin-fixed paraffin-embedded (FFPE) tissues for HPV genotyping by reverse blot hybridization assays (REBA) has not been clearly confirmed in retrospective studies. The aim of this study was to evaluate the usefulness and efficiency of FFPE tissues from cervical cancers for HPV genotyping. HPV genotypes were detected in 52 FFPE tissues from cervical carcinoma specimens by REBA. HPV was detected in 32 (61.5%) of 52 specimens from FFPE, among which 27 (84.4%) harbored single infections and 5(15.6%) contained multiple infections. The HPV single infections (27) were analyzed by high-risk type 18(8), 58(6), 16(5), 33(1), 35(1), 39(1), 56(1) and low risk type 11(2), 6(1), 70(1). The HPV multiple infections (5) included 16/18(2), 18/52(1), 16/56(1), 16/18/33(1). Please consider being more specific here. Do you mean the analysis? Please clarify what you mean by "included."Through this study, it has been determined that the FFPE specimen is feasible and can be used in HPV genotyping, as well as in retrospective studies.

Analysis of Pretreatment Prognostic Factors in Stage IIB Carcinoma of the Uterine Cervix (자궁경부암 IIB 병기에서의 치료전 예후 인자의 분석)

  • Shin, Kyung-Hwan;Ha, Sung-Whan;Yoo, Keun-Young
    • Radiation Oncology Journal
    • /
    • v.10 no.2
    • /
    • pp.227-236
    • /
    • 1992
  • From March 1979 through December 1986, 232 previously untreated patients with invasive carcinoma of the uterine cervix stage IIB were treated at the Department of Therapeutic Radiology, Seoul National University Hospital. The patients studied were staged according to the FIGO recommendations and the majority of patients were treated with external beam whole pelvis radiation and intracavitary radiation. Pretreatment parameters, including physical examination findings, blood parameters, prior medical illnesses, histology and abdomino-pelvic CT findings were studied, employing univariate and multivariate analyses to identify the potentially significant prognostic factors on locoregional control, disease free survival and overall survival. Histology, extent of parametrial involvement on physical examination and paraaortic lymph node metastasis on CT were found to have prognostic significance in the carcinoma of uterine cervix stage IIB.

  • PDF

Uterine Cervical Cancer: Emphasis on Revised FIGO Staging 2018 and MRI (자궁경부암: 개정된 2018 FIGO 병기와 자기공명영상을 중심으로)

  • Weon Jang;Ji Soo Song
    • Journal of the Korean Society of Radiology
    • /
    • v.82 no.5
    • /
    • pp.1083-1102
    • /
    • 2021
  • Uterine cervical cancer is a common gynecological cancer prevalent in Korea. Early detection, precise diagnosis, and appropriate treatment can affect its prognosis. Imaging approaches play an important role in staging, treatment planning, and follow-up. MRI specifically provides the advantage of assessing tumor size and disease severity with high soft tissue contrast. The revised version of the International Federation of Gynecology and Obstetrics (FIGO) staging system has been introduced in 2018, which incorporates subdivided primary tumor size and lymph node metastasis. In this review, the staging of uterine cervical cancer based on previous studies, the recently revised FIGO staging, and various post-treatment images are primarily described using MRI.

Role of FDG-PET in the Diagnosis of Recurrence and Assessment of Therapeutic Response in Cervical Cancer and Ovarian Cancer Patients: Comparison of Diagnostic Report between PET, Abdominal a and Tumor Marker (자궁경부암 및 난소암 환자 재발진단과 치료반응평가에 있어서 FDG-PET의 역할: 양전자방출단층촬영, 복부전산화단층촬영 및 종양표지자 판독의 비교 분석)

  • Han, You-Mie;Choe, Jae-Gol;Kang, Bung-Chul
    • Nuclear Medicine and Molecular Imaging
    • /
    • v.42 no.3
    • /
    • pp.201-208
    • /
    • 2008
  • Purpose: We aimed to assess the role of positron emission tomography using fluorodeoxyglucose (FDG-PET) in the diagnosis of recurrence or the assessment of therapeutic response in cervical and ovarian cancer patients through making a comparison between FDG-PET, abdominal computed tomography (CT) and serum tumor marker. Materials and methods: We included 103 cases (67 patients) performed FDG-PET and abdominal CT. There were 42 cervical cancers and 61 ovarian cancers. We retrospectively reviewed the interpretations of PET and CT images as well as the level of tumor marker. We calculated their sensitivity, specificity, positive predictive value and negative predictive value for these three modalities. And then we analyzed the differences between these three modalities. Results: Tumor recurrences were diagnosed in 37 cases (11 cervical cancers and 26 ovarian cancers). For PET, CT and tumor marker, in cervical cancer group, sensitivity was 100% (11/11), 54.5% (6/11) and 81.1% (9/11), respectively. And specificity was 93.6% (29/31), 93.6% (29/31) and 100% (31/31). In ovarian cancer group, sensitivity was 96.2% (25/26), 84.6% (22/26) and 80.8% (21/26), and specificity was 94.3% (33/35), 94.3% (33/35), 94.3% (33/35), PET was highly sensitive to detect the intraperitoneal and extraperitoneal metastasis with the help of the CT images to localize the lesions. However, CT had limitations in differentiation of the recurrent tumor from benign fibrotic tissue, identification of viable tumors at the interface of tissues, and detecting extraperitoneal lesions. Conclusion: FDG-PET can be an essential modality to detect the recurrent or residual tumors in gynecologic cancer patients because of its great field of the application and high sensitivity.

Convergence factors influencing the human papillomavirus vaccination in some female university students (일부 여대생의 인유두종바이러스 백신 접종에 영향을 미치는 융복합적 예측요인)

  • Lee, Hye-Ran;Oh, Yun-Jung
    • Journal of Digital Convergence
    • /
    • v.13 no.12
    • /
    • pp.235-244
    • /
    • 2015
  • This study was done to identify convergence factors influencing the HPV vaccination in female university students. The subjects of this study were 546 female university students. The data were collected through interviews using a structured questionnaire from 5 to 30th of October, 2013. 138(25.3%) reported that they were vaccinated. Religion, ever heard cervical cancer, HPV and cervical cancer vaccination, ever had a pap test, knowledge about HPV vaccination, health beliefs(total), perceived benefit, perceived barrier, cancer preventive behavior(total) and cervical cancer preventive behavior were associated with being vaccinated. In logistic regression analysis showed that the predictors are ever had a pap test(OR=34.67, 95% CI=17.19~ 69.92), perceived benefit(OR=1.45, 95% CI=1.17~1.81) and perceived barrier(OR=1.44, 95% CI=1.27~1.63). It was recommended to make convergence policy supports and education programs reinforcing a pap test and perceived benefit and reducing perceived barriers about HPV vaccination.

A Study of Relationship between the Level of Serum SCC Antigen and Recurrence Patterns after Treatment of Uterine Cervix Cancer (자궁경부암 치료 후 재발양상과 종양표지자 SCC항원의 혈청 수치 변화의 상관관계에 관한 연구)

  • Choi, Doo-Ho;Kim, Eun-Seog;Nam, Kae-Hyun
    • Radiation Oncology Journal
    • /
    • v.17 no.2
    • /
    • pp.120-129
    • /
    • 1999
  • Purpose : Serum squamous cell (SCC) antigen levels were examined in uterine cervix cancer undergoing radiation therapy, and authors analyzed the relationship between SCC antigen levels and treatment results. Materials and Methods :This is a retrospective study of 181 conical carcinoma patients who received radiotherapy and examined serial serum SCC antigen from 1991 to 1997 at Soonchunhyang University Hospital. One hundred and eighteen patients underwent SCC antigen evaluation at diagnosis The relationship between the serum tumor marker level and disease free survival, recurrence pattern, and other prognostic factors were analyzed according to various statistical methods. Results : The Positivity rate (initial serum value above 2.5 ng/ml) was increased with FIGO stage (IB-IIA 57% to IV 91%) and more discriminative than cutoff value of 1.5 ng/ml. Five year disease free survival rates for the stage IB-IIA, IIB, III and IV were 79.2%, 68.7%, 33.4% and 0%, respectively. The 5-year disease free survival rate for patients with serum SCC antigen levels above 5.0 ng/ml was 34% versus 55~62% for patients with normal range (>1.5 ng/ml) or mildly elevated levels (1.5~5.0 ng/ml). Rising SCC antigen levels preceded the clinical detection of disease by a mean of 4.8 months (range 1 ~13 months). Negative linear correlation was observed between initial SCC antigen levels and relapse free survival (r=-0.226), and by multivariate analysis, initial SCC antigen level had a large impact on the relapse free survival. Conclusion : SCC antigen assay is a useful aid to predict the prognosis of squamous cell carcinoma of the uterine cervix and to detect recurrence.

  • PDF

Convergence research on cytological diagnosis of gynecological diseases and genital HPV : Based on data from the Obstetrics and Gynecology Department of a general hospital located in Suwon-si (수원시 소재 일개 종합병원 산부인과에서 자궁경부 질환 검사의 실태조사 : HPV와 세포학적 검사의 융합연구)

  • Joung, You Hyun;Lee, Jun Min;Kim, Jong-Wan;Kim, Jae Kyung
    • Journal of the Korea Convergence Society
    • /
    • v.13 no.1
    • /
    • pp.119-129
    • /
    • 2022
  • Cervical cytology has been widely used as a screening tool for cervical cancer. However, Human papillomavirus (HPV) detection and subtype testing are suggested to overcome the high false-negative rate associated with cytology. We aimed to investigate the clinical usefulness and infection rate in the HPV polymerase chain reaction (PCR) test performed in hospitals. HPV PCR data from 217 patients were analyzed. Analysis of variance revealed a significant difference in the infection rate among different age groups (P=0.015). The biopsy results showed that epithelial cell abnormalities and high HPV-positivity rate was observed in 1 (100%) subject aged <29 years, in 4 out of 5 (80%) patients in their 30s, and in 3 out of 4 (75%) patients aged ≥70 years. The prevalence of HPV infection was very high (46.1%). The highest prevalence (87.5%) was observed among patients in their <29, followed by those in their 30s (67.7%) and those in their 40s (31.9%).A high rate of epithelial cell abnormalities (≥ cervical intraepithelial neoplasia type 1, mild dysplasia) was observed in HPV-infected women aged<30 years. Therefore, extensive research and prevention activities are needed in this age group. HPV PCR testing is recommended to complement cervical cytology